Company Analysis RPG Life Sciences Limited
1. Summary
Advantages
- The stock's return over the last year (40.69%) is higher than the sector average (12.14%).
- Current debt level 0.0019% is below 100% and has decreased over 5 years from 13.25%.
- The company's current efficiency (ROE=25.69%) is higher than the sector average (ROE=10.72%)
Disadvantages
- Price (2059.1 βΉ) is higher than fair price (763.53 βΉ)
- Dividends (1.74%) are below the sector average (9.58%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| RPG Life Sciences Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -3.7% | -1.9% | 0.1% |
| 90 days | -9.3% | -12.6% | -8.1% |
| 1 year | 40.7% | 12.1% | 1.5% |
RPGLIFE vs Sector: RPG Life Sciences Limited has outperformed the "Healthcare" sector by 28.55% over the past year.
RPGLIFE vs Market: RPG Life Sciences Limited has outperformed the market by 39.22% over the past year.
Stable price: RPGLIFE is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: RPGLIFE with weekly volatility of 0.7825% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2059.1 βΉ) is higher than the fair price (763.53 βΉ).
Price is higher than fair: The current price (2059.1 βΉ) is 62.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (28.66) is lower than that of the sector as a whole (59.64).
P/E vs Market: The company's P/E (28.66) is lower than that of the market as a whole (64.71).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.7) is higher than that of the sector as a whole (6.64).
P/BV vs Market: The company's P/BV (6.7) is higher than that of the market as a whole (6.37).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.32) is lower than that of the sector as a whole (9.32).
P/S vs Market: The company's P/S indicator (4.32) is lower than that of the market as a whole (18.79).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (18.28) is lower than that of the sector as a whole (141.6).
EV/Ebitda vs Market: The company's EV/Ebitda (18.28) is lower than that of the market as a whole (34.47).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 40.43% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (40.43%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-4.48%).
5.4. ROE
ROE vs Sector: The company's ROE (25.69%) is higher than that of the sector as a whole (10.72%).
ROE vs Market: The company's ROE (25.69%) is higher than that of the market as a whole (3.59%).
5.5. ROA
ROA vs Sector: The company's ROA (18.81%) is higher than that of the sector as a whole (7.64%).
ROA vs Market: The company's ROA (18.81%) is higher than that of the market as a whole (7.91%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (28.44%) is higher than that of the sector as a whole (15.91%).
ROIC vs Market: The company's ROIC (28.44%) is higher than that of the market as a whole (15.54%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 1.74% is below the average for the sector '9.58%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.74% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 1.74% has been growing weakly or stagnant over the past 5 years. Growth over only 4 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (22.64%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
